Today: 16 May 2026
Browse Category

Earnings Reports 26 January 2026

Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks shares fell 1.4% to $96.22 Monday, trailing a broader market rally ahead of its fiscal Q1 earnings report Wednesday and Investor Day Thursday. Volume reached 8.1 million shares. Analysts cited steady sales but ongoing margin pressures from higher coffee and labor costs. Peers traded mixed, with McDonald’s up 1.1% and Dutch Bros down 2.8%.
26 January 2026
··
Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare shares surged 11.5% to $193.30 Monday, outpacing sector rivals after social media buzz around “Clawdbot,” an open-source AI agent built on Anthropic’s Claude. Wolfe Research linked the rally to expectations that Cloudflare’s network could benefit if AI-driven traffic rises. Investors await Cloudflare’s Feb. 10 earnings and the Federal Reserve’s policy decision this week. Akamai, Fastly, and Zscaler also posted gains.
26 January 2026
···
Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer shares rose 0.7% to $25.84 in Monday afternoon trading, tracking a broader U.S. stock rally ahead of major earnings and a Federal Reserve policy decision. Investors are watching for Pfizer’s Feb. 3 earnings and updates on its 2026 outlook, as the company faces falling COVID demand and looming patent expirations. Trading volume remained moderate, with no major company news released.
26 January 2026
····
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific shares rose 1.7% to $94.12 Monday, outpacing medical-device peers and the S&P 500. Evercore reaffirmed its Outperform rating and $112 target, dismissing concerns about the $14.5 billion Penumbra acquisition. Investors await the Feb. 4 earnings call for updates on integration, financing, and demand trends. The Penumbra deal is expected to close in 2026.
26 January 2026
··
Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments shares rose 1.5% to $196.20 Monday, outpacing a flat semiconductor sector ahead of its quarterly earnings report due Tuesday after markets close. Analysts expect EPS of $1.29 on $4.44 billion revenue. CEO Haviv Ilan and CFO Rafael Lizardi will lead the earnings call at 3:30 p.m. Central. Investors are watching for signs of recovery in industrial and automotive chip demand.
26 January 2026
··
AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie shares rose 0.4% to $220.10 Monday, moving between $217.15 and $221.48 as investors awaited its Feb. 4 earnings report. Health-care stocks held firm, with the sector ETF up 0.4% and Johnson & Johnson and Pfizer also gaining. AbbVie’s upcoming results will highlight its immunology drugs as it faces pressure from declining Humira sales and recent policy deals. Traders are watching Wednesday’s Fed decision before the earnings release.
26 January 2026
···
GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova shares rose 1.7% to $669.04 Monday afternoon ahead of its quarterly earnings report, due before markets open Jan. 28. Morgan Stanley maintained an Overweight rating but lowered its price target to $817. Wall Street expects earnings of $3.03 per share on $10.04 billion revenue. The report coincides with the Federal Reserve’s policy decision Wednesday.
26 January 2026
··
Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar shares rose 1.7% to $637.22 Monday, with 1.3 million shares traded ahead of its Jan. 29 earnings report. Analysts expect higher revenue but lower profit, projecting $4.67 per share on $17.89 billion. Options pricing signals a possible 6% move after results. The Federal Reserve’s Jan. 27-28 meeting and ongoing tariffs add uncertainty for machinery stocks.
26 January 2026
···
Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola shares slipped 0.1% to $72.83 Monday afternoon as investors awaited the Federal Reserve’s Jan. 27-28 policy decision. The broader consumer staples sector also declined, while PepsiCo rose 0.7%. Coca-Cola will report fourth-quarter and full-year results on Feb. 10. The company recently announced leadership changes, including a new chief digital officer.
26 January 2026
···
Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

The Dow Jones rose 0.6% to 49,403 Monday afternoon, led by Apple and Cisco, while UnitedHealth and 3M lagged. Gold and silver hit new records as the dollar weakened. The Federal Reserve begins a two-day meeting Tuesday, with rates expected to hold steady. Investors await earnings from major tech firms and the Fed’s decision Wednesday.
26 January 2026
·········
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
26 January 2026
··
SoFi stock price ticks higher as traders brace for Friday earnings and the Fed

SoFi stock price ticks higher as traders brace for Friday earnings and the Fed

SoFi Technologies shares rose 0.6% to $26.00 by midday Monday, with about 19 million shares traded. Investors are watching for SoFi’s Q4 and full-year earnings Friday and the Federal Reserve’s policy decision Wednesday. Peers showed mixed moves, with Affirm down and Upstart, PayPal up slightly. The Fed is expected to hold rates steady at 3.50%–3.75%.
26 January 2026
···
Boeing stock price today: BA slips as investors brace for earnings and 737 MAX clues

Boeing stock price today: BA slips as investors brace for earnings and 737 MAX clues

Boeing shares fell 0.6% to $250.53 in midday trading Monday ahead of Tuesday’s fourth-quarter results. Investors are focused on 737 production rates, cash flow, and certification delays, with Boeing aiming to boost output beyond 38 jets a month. FAA approval for the MAX 7 and MAX 10 remains pending due to engine de-icing issues. Boeing reported 160 commercial deliveries in the fourth quarter, pending final results.
26 January 2026
··
Robinhood (HOOD) stock inches higher as Fed week kicks off; Feb. 10 earnings loom

Robinhood (HOOD) stock inches higher as Fed week kicks off; Feb. 10 earnings loom

Robinhood shares rose 0.8% to $107.88 by midday Monday after an early drop, trading between $104.85 and $108.47 on volume of 7 million. Peers were mixed, with Coinbase down 1.7% and Schwab up 1%. Investors are watching the Fed’s Wednesday rate decision and Robinhood’s Feb. 10 earnings. Robinhood’s joint venture with Susquehanna closed its purchase of 90% of MIAXdx last week.
26 January 2026
··
1 … 94 95 96 97 98 … 248

Stock Market Today

  • Stantec Q1 2026 Reports Record Backlog and Revenue Growth Despite Weaker Share Price
    May 16, 2026, 1:54 AM EDT. Stantec reported a record C$9 billion backlog and strong Q1 2026 revenue of about C$1.7 billion, with net income of C$110.8 million, beating prior year figures and market estimates. The backlog equates to roughly 13 months of contracted work in Water, Buildings, and Energy & Resources sectors. Management reaffirmed 2026 guidance for 8.5%-11.5% revenue growth and targets for adjusted earnings per share growth and margin expansion. Despite these operational gains, the share price dropped 11% in the past week, down 19.4% year to date. The stock remains up 37% over three years. Stantec also declared a quarterly dividend of C$0.245 and maintained operational carbon neutrality, appealing to sustainability-focused investors. Market watchers will monitor backlog conversion and execution in upcoming quarters to validate growth momentum.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop